Your Health, We Care
With the increase of the global aging population and the improvement of health awareness among menopausal women, the market demand for Fezolinetant continues to grow. According to Evaluate Pharma's prediction, Fezolinetant's sales will reach $1.9 billion by 2028.
Anstelai has applied for patent protection in China for the salt form, solvate form, and crystal form of non zolpidem. The application and protection of these patents undoubtedly provide strong support for the commercialization of non zolpidem tablets.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
